Cargando…
Pharmacovigilance Analysis of Heart Failure Associated With Anti-HER2 Monotherapies and Combination Regimens for Cancer
BACKGROUND: Trastuzumab improves outcomes in patients with HER2-overexpressing malignancies but is associated with decreases in left ventricular ejection fraction. Heart failure (HF) risks from other anti-HER2 therapies are less clear. OBJECTIVES: Using World Health Organization pharmacovigilance da...
Autores principales: | Waliany, Sarah, Caswell-Jin, Jennifer, Riaz, Fauzia, Myall, Nathaniel, Zhu, Han, Witteles, Ronald M., Neal, Joel W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982216/ https://www.ncbi.nlm.nih.gov/pubmed/36875913 http://dx.doi.org/10.1016/j.jaccao.2022.09.007 |
Ejemplares similares
-
Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor
por: Waliany, Sarah, et al.
Publicado: (2019) -
The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity
por: Huang, Yuhsin Vivian, et al.
Publicado: (2022) -
Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors
por: Waliany, Sarah, et al.
Publicado: (2021) -
Lamivudine monotherapy as a holding regimen for HIV-positive children
por: Patten, Gabriela, et al.
Publicado: (2018) -
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
por: Jeung, H-C, et al.
Publicado: (2006)